Literature DB >> 29909930

Interventional Radiology Management of Vascular Obstruction.

Marilyn Dunn1, Brian A Scansen2.   

Abstract

Vascular obstructions in small animals have numerous etiologies and variable signs depending on location and chronicity. The decision to treat and by which method (medical, interventional, surgical) can be challenging. A combined approach of catheter-directed thrombolysis, angioplasty, or vascular stenting may be most appropriate for acute thrombosis, though optimal therapeutic strategies are undefined in this population. The role of embolic trapping devices in animals is uncertain. Chronic cases of vascular obstruction, with collateral flow and neither ischemia nor venous congestion manifest, may be conservatively managed. Prospective clinical studies are needed to better guide management of vascular obstructions in veterinary medicine.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Angioplasty; Canine; Coagulation; Feline; Intervention; Stent; Thrombosis

Mesh:

Year:  2018        PMID: 29909930     DOI: 10.1016/j.cvsm.2018.05.004

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  3 in total

1.  Outcome and treatments of dogs with aortic thrombosis: 100 cases (1997-2014).

Authors:  Mackenzie Ruehl; Alex M Lynch; Therese E O'Toole; Bari Morris; John Rush; C Guillermo Couto; Samantha Hmelo; Stacey Sonnenshein; Amy Butler; Julien Guillaumin
Journal:  J Vet Intern Med       Date:  2020-08-15       Impact factor: 3.333

2.  Stenting of the caudal aorta and aortic trifurcation for the treatment of thrombosis in 7 dogs.

Authors:  Kelly A Gavin; Chick Weisse; Allyson C Berent
Journal:  J Vet Intern Med       Date:  2022-02-07       Impact factor: 3.333

3.  Transatrial stenting for long-term management of cardiac tumor obstruction of the right atrium in 3 dogs.

Authors:  Chick Weisse; Brian A Scansen; Allyson C Berent; Rick E Cober
Journal:  J Vet Intern Med       Date:  2020-12-18       Impact factor: 3.175

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.